ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0901

Intergenic Alu Elements Are Uniquely Expressed in Dermatomyositis and Correlate with Interferon Stimulated Genes

Rayan Najjar1, Andrew Mammen2 and Tomas Mustelin1, 1University of Washington, Seattle, WA, 2NIH, Bethesda, MD

Meeting: ACR Convergence 2024

Keywords: genomics, informatics, interferon, Myositis, Non-coding RNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: As genes constitute < 2% of our genomes, there is a need to explore potential roles of other genomic elements in autoimmune disease. We focus on short interspersed elements (SINEs) in this study. They are 260-300 bp elements that occupy roughly 13% of our genomes. There are two major types of SINEs: Alu elements, and mammalian-wide interspersed repeats (MIRs). SINEs have been implicated in multiple biologic functions including gene transcription regulation, alternative splicing, nuclear retention, mRNA decay, and forming double stranded RNA that can trigger interferon signaling. In addition, Alus play a role in binding of NF-κB to the IFN-β enhancer.

Methods: We aligned muscle biopsy RNA-sequencing data (n=152) to the T2T reference genome, which is the first truly complete human genome, and quantified the expression of SINEs at the locus level. Analysis was done by myositis group (dermatomyositis [DM]=39, anti-synthetase syndrome [AS]=15, immune-mediated necrotizing myopathy [IMNM]=51, inclusion body myositis [IBM]=15) vs normal control (n=32). After differential expression testing by myositis groups (alpha=0.05), SINEs with unique expression in each group were identified. SINEs can be expressed passively with gene transcription when they’re embedded in exons or introns; or they can be transcribed through their own promotors. Therefore, we classified SINEs based on their genomic coordinates into those that fall inside: exons, introns, promoter regions, or outside these regions (intergenic). Finally, we correlated the top 10 differentially expressed SINEs by group to interferon stimulated genes (ISGs). P values were adjusted for multiple comparisons.

Results: There were many differentially expressed SINEs in each myositis group vs controls (range 1,749-4,568 elements). Uniquely expressed SINEs with ≥2 fold change were highest in DM (740 elements, vs a range of 134-233 in other groups). DM had 620 overexpressed SINES (93% Alu elements), and 120 underexpressed SINEs (56% MIRs), see Figure 1. While IMNM was the only group with more underexpressed (n=140) than overexpressed elements (n=93). In contrast to DM, AS had more MIRs (n=45) than Alus (n=39) that were overexpressed, and mostly underexpressed Alus (n=44), compared with underexpressed MIRs (n=6). Overall, most SINEs were intergenic, including in DM (79%). Of the top 10 differentially expressed Alus in DM, eight were linearly correlated with high ISGs, including three intergenic elements (Figure 2) with strong correlation coefficients (0.81-0.85, q value < 1.0e-36, Figure 3). Similar analyses showed weaker associations of ISGs with top expressed SINEs in AS and IBM, and no significant associations in IMNM.

Conclusion: DM is characterized by unique expression of hundreds of Alu elements that are not seen in other myositis types or in normal muscle. The majority of these Alus were intergenic indicating that they were likely transcribed primarily through their own promotors, and not through passive transcription inside introns and exons of transcribed genes. This analysis reveals a new aspect of the altered biology in dermatomyositis that has not been described before, opening new research avenues to unravel the pathogenesis of myositis.

Supporting image 1

Frequencies of unique differentially expressed SINEs by myositis group, SINE family, and direction of change

Supporting image 2

Three intergenic Alu elements with unique overexpression in dermatomyositis

Supporting image 3

Correlation of interferon stimulated genes with expression of three intergenic Alu elements in myositis samples. r= Pearson correlation coefficient, q= p value adjusted for multiple comparisons, ISG=Interferon stimulated gene


Disclosures: R. Najjar: None; A. Mammen: None; T. Mustelin: Bristol-Myers Squibb(BMS), 2, Cugene, 2, Miro Bio, 2, QiLu Bopharma, 2, Rome therapeutics, 2.

To cite this abstract in AMA style:

Najjar R, Mammen A, Mustelin T. Intergenic Alu Elements Are Uniquely Expressed in Dermatomyositis and Correlate with Interferon Stimulated Genes [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/intergenic-alu-elements-are-uniquely-expressed-in-dermatomyositis-and-correlate-with-interferon-stimulated-genes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intergenic-alu-elements-are-uniquely-expressed-in-dermatomyositis-and-correlate-with-interferon-stimulated-genes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology